Wednesday, July 8, 2026

biotech · Lupus Nephritis - WHO Class III · Non Hodgkin Lymphoma · ARTV

Artiva Biotherapeutics

News and analysis for Artiva Biotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

San Diego, USA HQ
2019 Founded
105 Employees
Public company Type
ARTV · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2019
Employees
105
Programs
8
Drugs
9
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Artiva Biotherapeutics — regulatory, clinical, and market coverage.

News and analysis for Artiva Biotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Artiva Biotherapeutics yet.

Back to company overview →